Turbine Partners with MSD to AI-Study Hard-to-Treat Cancers
Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient populations that remain difficult to treat and study in laboratory settings. To develop novel treatments for patients, scientists must first understand the biological…
